These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Modulation of cytosolic and intra-sarcoplasmic reticulum calcium waves by calsequestrin in rat cardiac myocytes. Kubalova Z; Györke I; Terentyeva R; Viatchenko-Karpinski S; Terentyev D; Williams SC; Györke S J Physiol; 2004 Dec; 561(Pt 2):515-24. PubMed ID: 15486014 [TBL] [Abstract][Full Text] [Related]
26. Probing cationic selectivity of cardiac calsequestrin and its CPVT mutants. Bal NC; Jena N; Sopariwala D; Balaraju T; Shaikh S; Bal C; Sharon A; Gyorke S; Periasamy M Biochem J; 2011 Apr; 435(2):391-9. PubMed ID: 21265816 [TBL] [Abstract][Full Text] [Related]
27. Accelerated sinus rhythm prevents catecholaminergic polymorphic ventricular tachycardia in mice and in patients. Faggioni M; Hwang HS; van der Werf C; Nederend I; Kannankeril PJ; Wilde AA; Knollmann BC Circ Res; 2013 Feb; 112(4):689-97. PubMed ID: 23295832 [TBL] [Abstract][Full Text] [Related]
28. Clinical phenotype and functional characterization of CASQ2 mutations associated with catecholaminergic polymorphic ventricular tachycardia. di Barletta MR; Viatchenko-Karpinski S; Nori A; Memmi M; Terentyev D; Turcato F; Valle G; Rizzi N; Napolitano C; Gyorke S; Volpe P; Priori SG Circulation; 2006 Sep; 114(10):1012-9. PubMed ID: 16908766 [TBL] [Abstract][Full Text] [Related]
29. Viral delivered gene therapy to treat catecholaminergic polymorphic ventricular tachycardia (CPVT2) in mouse models. Kurtzwald-Josefson E; Yadin D; Harun-Khun S; Waldman M; Aravot D; Shainberg A; Eldar M; Hochhauser E; Arad M Heart Rhythm; 2017 Jul; 14(7):1053-1060. PubMed ID: 28336343 [TBL] [Abstract][Full Text] [Related]
30. Catecholaminergic polymorphic ventricular tachycardia from bedside to bench and beyond. Katz G; Arad M; Eldar M Curr Probl Cardiol; 2009 Jan; 34(1):9-43. PubMed ID: 19068246 [TBL] [Abstract][Full Text] [Related]